Emerging Infections and Transfusion Safety

Practical Transfusion Medicine

Volumn , Issue , 2013, Pages 161-167

  Dodd, Roger Y ^a  

^a HOLLAND LABORATORY   (United States)

Author keywords

Blood safety; Emerging infectious diseases; Transfusion

Indexed keywords

EID: 84886533249     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781118520093.ch16     Document Type: Chapter

References (19)

1. Morens DM, Folkers GK & Fauci AS. Emerging infections: a perpetual challenge. Lancet Infect Dis 2008; 8: 710-719.
2. Stramer SL, Hollinger FB, Katz LM, Kleinman S, Metzel PS, Gregory KM & Dodd RY. Emerging infectious disease agents and their potential threat to transfusion safety. Transfusion 2009; 49 (Suppl.): 1S-233S.
3. http://www.promedmail.org/.
4. Glynn SA, Kleinman SH, Wright DJ & Busch MP. NHLBI Retrovirus Epidemiology Study. International application of the incidence rate/window period model. Transfusion 2002; 42: 966-972.
5. Klein HG, Dodd RY, Hollinger FB, Katz LM, Kleinman S, McCleary KK, Silverman RH & Stramer SL, for the AABB Interorganizational Task Force on XMRV. Xenotropic murine leukemia virus-related virus (XMRV) and blood transfusion: Report of the AABB Interorganizational XMRV Task Force. Transfusion 2011; 51: 654-661.
6. Simmons G, Glynn SA, Holmberg JA, Coffin JM, Hewlett IK, Lo SC, Mikovits JA, Switzer WM, Linnen JM & Busch MP, for the Blood XMRV Scientific Research Working Group (SRWG). The blood xenotropic murine leukemia virus-related virus scientific research working group: mission, progress, and plans. Transfusion 2011; 51: 643-653.
7. Simmons G, Glynn SA, Komaroff AL, Mikovits JA, Tobler LH, Hackett Jr J, Tang N, Switzer WM, Heneine W, Hewlett IK, Zhao J, Lo SC, Alter HJ, Linnen JM, Gao K, Coffin JM, Kearney MF, Ruscetti FW, Pfost MA, Bethel J, Kleinman S, Holmberg JA & Busch MP, for the Blood XMRV Scientific Research Working Group (SRWG). Failure to confirm XMRV/MLV in the blood of patients with chronic fatigue syndrome: a multilaboratory study. Science 2011; 334: 814-817.
8. Biggerstaff BJ & Petersen LR. Estimated risk of West Nile virus transmission through blood transfusion during an epidemic in Queens, New York City. Transfusion 2002; 42: 1019-1026.
9. Hewitt PE, Llewelyn CA, Mackenzie J & Will RG. Creutzfeldt-Jakob disease and blood transfusion: results of the UK Transfusion Medicine Epidemiological Review study. Vox Sanguinis 2006; 91: 221-230.
10. Dodd RY. Perspective: emerging infections, transfusion safety and epidemiology. New Engl J Med 2003; 349: 1205-1206.
11. Benjamin RJ, Stramer SL, Leiby DA, Dodd RY, Fearon M & Castro E. Trypanosoma cruzi infection in North America and Spain: evidence in support of transfusion transmission. Transfusion 2012. Early online publication, DOI: 10.1111/j.1537-2995.2011.03554.x.
12. Wilson K & Ricketts MN. The success of precaution? Managing the risk of transfusion transmission of variant Creutzfeldt-Jakob disease. Transfusion 2004; 44: 1475-1478.
13. Alter HJ, Stramer SL & Dodd RY. Emerging infectious diseases that threaten the blood supply. Semin Hematol 2007; 44: 32-41.
14. Biggerstaff BJ & Petersen LR. Estimated risk of transmission of the West Nile virus through blood transfusion in the US, 2002. Transfusion 2003; 43: 1007-1017.
15. Dodd RY & Leiby DA. Emerging infectious threats to the blood supply. Annual Rev Med 2004; 55: 191-207.
16. Mackenzie JS, Gubler DJ & Petersen LR. Emerging flaviviruses: the spread and resurgence of Japanese encephalitis, West Nile and dengue viruses. Nat Med (Suppl.) 2004; 10(12): S98-S108.
17. Stramer SL, Fang CT, Foster GA, Wagner AG, Brodsky JP & Dodd RY. West Nile virus among blood donors in the United States, 2003 and 2004. N Engl J Med 2005; 353: 451-459.
18. Tomashek KM & Margolis HS. Dengue: a potential transfusion-transmitted disease. Transfusion 2011; 51: 1654-1660.
19. Weiss RA & McMichael AJ. Social and environmental risk factors in the emergence of infectious disease. Nat Med (Suppl.) 2004; 10(12): S70-S76.